Cargando…
The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis
As an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the common signs of coronavirus disease 2019 (COVID-19) are respiratory symptoms, fever, cough, shortness of breath, and dyspnea, with multiple organ injuries in severe cases. Therefore, finding drug...
Autores principales: | Wang, Xin-Chen, Wu, Guang-Liang, Cai, Ye-Feng, Zhang, Shi-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524532/ https://www.ncbi.nlm.nih.gov/pubmed/36181086 http://dx.doi.org/10.1097/MD.0000000000030874 |
Ejemplares similares
-
The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
por: Huang, Po-Yu, et al.
Publicado: (2023) -
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
por: Ramos, Eva, et al.
Publicado: (2021) -
Efficacy and safety of baricitinib in patients with severe COVID-19: A systematic review and meta-analysis
por: Song, Wenxin, et al.
Publicado: (2023) -
Systematic Review and Meta-analysis of Efficacy and Safety of Melatonin and Triclofos for Inducing Adequate Sedation for Sleep Electroencephalogram in Children
por: Panda, Prateek K., et al.
Publicado: (2021) -
Efficacy and safety of baricitinib for the treatment of hospitalized adults with COVID-19: a systematic review and meta-analysis
por: Sun, Jing, et al.
Publicado: (2023)